John is a seasoned finance executive with more than 20 years of experience in financial and business planning. Previously, John served as Chief Financial Officer at HUYA Bioscience International, where he played a pivotal role in the company’s strategic direction, including evaluating licensing candidates, tax strategies and all financial activities. Prior to HUYA, John was Chief Financial Officer at Ligand Pharmaceuticals. In this position, he oversaw accounting, treasury, tax and U.S. Securities and Exchange Commission reporting, in addition to financial and operational due diligence on multiple assets and business acquisitions. John also held financial leadership roles at Sequenom, Inc., and Diversa Corporation, and began his career as an auditor at PricewaterhouseCoopers LLP. John received a BS in business administration with an emphasis in accounting from San Diego State University and is a certified public accountant (inactive) in California.